Please login to the form below

Not currently logged in

Russia says its Sputnik V COVID-19 vaccine is 91.4% effective


Preliminary data demonstrates efficacy of 95% after 42 days

Pfizer doses first patient in investigational haemophilia drug trial

Pfizer logoCompany is evaluating marstacimab in severe haemophilia A/B patients

AZ’s COVID-19 vaccine demonstrates efficacy rate of up to 90%

AZ NEWAcross two dosing regimens, vaccine has average efficacy of 70%

Chief investigator of Oxford Vaccine Group says data could be released before Christmas

Vaccine vialAstraZeneca is developing a COVID-19 vaccine with Oxford University

AZ’s COVID-19 vaccine proves promising in elderly participants, new data shows

AZ NEWImmune responses were similar in younger and older adults

Sinovac’s COVID-19 vaccine produces antibody response in mid-stage study

covidLevel of antibodies in vaccinated group lower than recovered COVID-19 patients

J&J advances COVID-19 vaccine into second phase 3 trial

J&J cottonwood driveENSEMBLE study will enrol 60,000 people worldwide

Moderna’s COVID-19 vaccine is 94.5% effective, initial data suggests

The UK government has secured access to five million doses of the vaccine

Synairgen’s SNG001 advances into phase 3 COVID-19 trial

Coronavirus newUK biotech had initially been testing drug for COPD and asthma

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...